CLL: Chemotherapy and Ibrutinib based regimens

CLL: Chemotherapy and Ibrutinib based regimens

Dr. Fakhri on Ibrutinib-Containing Regimens in CLLПодробнее

Dr. Fakhri on Ibrutinib-Containing Regimens in CLL

Dr. Smith on Ibrutinib-Based Therapies in CLLПодробнее

Dr. Smith on Ibrutinib-Based Therapies in CLL

The latest CLL treatments and therapies with Dr Jan BurgerПодробнее

The latest CLL treatments and therapies with Dr Jan Burger

Ibrutinib’s Role in Frontline Management of CLLПодробнее

Ibrutinib’s Role in Frontline Management of CLL

CLL: Rationale for Ibrutinib and ChemotherapyПодробнее

CLL: Rationale for Ibrutinib and Chemotherapy

Role of chemotherapy in CLL managementПодробнее

Role of chemotherapy in CLL management

ASCO 2015: New Ibrutinib Combination Regimen Shows Substantial Benefits in Relapsed CLLПодробнее

ASCO 2015: New Ibrutinib Combination Regimen Shows Substantial Benefits in Relapsed CLL

CLL Live 2015 - Dr. Michael Keating, 'American Perspective on CLL'Подробнее

CLL Live 2015 - Dr. Michael Keating, 'American Perspective on CLL'

Debate: Best Frontline Regimen for a CLL Patient Aged 60 Who Requires Therapy - IbrutinibПодробнее

Debate: Best Frontline Regimen for a CLL Patient Aged 60 Who Requires Therapy - Ibrutinib

Новости